Sourcing strategy

TWO CONTINENTS.
ONE STANDARD.

Voleni sources premium medical cannabis flower from trusted partners in Canada and South Africa, ensuring quality, consistency and long term supply security for UK patients.

Canada cultivation facility
01 · Canada

Canada.

World leading pharmaceutical grade cultivation.

Canada pioneered federally legal medical cannabis in 2001 and remains the global benchmark for indoor pharmaceutical grade cultivation. Voleni partners with licensed producers operating under Health Canada's strict GPP framework, combining indoor precision rooms and high tech greenhouses to deliver consistent, premium flower.

  • Indoor and hybrid greenhouse cultivation
  • Decades of cultivation research and genetic refinement
  • GMP certified facilities with proven EU export experience
  • Consistent cannabinoid and terpene profiles batch to batch
  • Established cold chain logistics into the UK and EU

Pharma grade

GMP & GPP certified production

Genetics

Award winning, stable cultivars

Reliability

Mature export infrastructure

South Africa cultivation facility
02 · South Africa

South Africa.

Premium quality at remarkable value.

South Africa combines world class indoor cultivation with high tech greenhouse operations, supported by 300+ days of sunshine, low energy costs and a skilled agricultural workforce. Our SAHPRA licensed partners operate under GACP and GMP standards, delivering premium flower at a fraction of pure indoor cost.

  • Both indoor cleanrooms and modern greenhouse facilities
  • Significantly lower production cost per gram
  • Scalable capacity for growing UK patient demand
  • SAHPRA licensed, GACP & GMP compliant operations
  • Direct export corridor to UK importers

Value

Best quality to price ratio

Scale

Hectares of licensed capacity

Sustainable

Lower energy & carbon footprint

Future ready

VOLENI OWN GENETICS

Voleni is building a vertically integrated future. From proprietary cultivars to UK cultivation, we are securing supply for the next decade.

Voleni proprietary cannabis clones in propagation

Proprietary clones

Mother stock to harvest, fully owned.

2027

Facilities operational.

Our own strain genetics will be grown in facilities ready for our import. Licensed cultivation infrastructure commissioned and producing first commercial batches under GACP.

2028

Voleni strains ready.

Voleni own strains that will be ready by 2028. Proprietary cultivars developed for the UK market, delivering consistent cannabinoid profiles and full traceability from seed to patient.

Seed to patient journey

  1. 01

    Austria TC lab

    Tissue culture mother stock, phytosanitary certified

  2. 02

    Transfer

    Sealed cold chain to licensed cultivation site

  3. 03

    Facility

    GACP cultivation, propagation to flower

  4. 04

    Harvest & cure

    GMP processing, lab tested batches

  5. 05

    Export to UK

    Licensed import, distributed to pharmacies

Genetic security

Tissue culture propagation.

Our proprietary strains are held in tissue culture at partner laboratories in Germany and Austria. This guarantees maximum security from pests, pathogens and genetic loss while maintaining absolute consistency across every batch.

All strains are fully licensed and legally registered with full phytosanitary documentation. They are ready to distribute through regulated channels across Europe.

Pest free

Complete protection from insects, mites and cross contamination in sealed sterile conditions.

Genetic fidelity

Exact clones with zero genetic drift, preserving the original cultivar profile indefinitely.

Disease free

Elimination of pathogens and viruses that can spread through conventional mother stock.

Rapid scale

Commercial volumes multiplied from a single explant to meet growing patient demand.

Cannabis tissue culture laboratory with sterile plant clones in jars
Germany & Austria

Our supply chain

Seed to patient.

Every gram passes through six audited stages, from licensed cultivation overseas to UK pharmacy dispensing.

01

Cultivation

GACP / GPP

02

Lab Testing

Independent

03

Packaging

Medical grade

04

Export

Cold chain

05

UK Import

MHRA licensed

06

Pharmacy

To patient

Supplier requirements

Non-negotiables.

GACP Standards

Good Agricultural and Collection Practice across every facility.

Quality Testing

Independent verification of potency, contaminants and microbiology.

Full Traceability

From seed to patient, every batch documented and accountable.

Secure Chain

Audited logistics, custody and storage at every stage.